Cargando…

Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer

Although the inhibitors of singly mutated epidermal growth factor receptor (EGFR) kinase are effective for the treatment of non-small cell lung cancer (NSCLC), their clinical efficacy has been limited due to the emergence of various double and triple EGFR mutants with drug resistance. It has thus be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hwangseo, Jung, Hoi-Yun, Kim, Kewon, Kim, Myojeong, Hong, Sungwoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730458/ https://www.ncbi.nlm.nih.gov/pubmed/33297461 http://dx.doi.org/10.3390/ijms21239323

Ejemplares similares

Structure-Based Virtual Screening and De Novo Design to Identify Submicromolar Inhibitors of G2019S Mutant of Leucine-Rich Repeat Kinase 2
por: Park, Hwangseo, et al.
Publicado: (2022)

Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products
por: Park, Hwangseo, et al.
Publicado: (2021)

Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review
por: Mansour, Mostafa A., et al.
Publicado: (2023)

Nucleophilic C4-selective (hetero) arylation of pyridines for facile synthesis of heterobiaryls
por: Kim, Kewon, et al.
Publicado: (2023)

Divergent reactivity of sulfinates with pyridinium salts based on one- versus two-electron pathways
por: Kim, Myojeong, et al.
Publicado: (2021)

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer
por: Lim, Sun Min, et al.
Publicado: (2023)

Symposium on Fourth Generation Computers
por: Grünberger, Fred
Publicado: (1970)

High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance
por: Wambaugh, Morgan A., et al.
Publicado: (2017)

Rationally Designed Antimicrobial Peptides Are Potential Tools to Combat Devastating Bacteria and Fungi
por: Váradi, Györgyi, et al.
Publicado: (2022)

Rational pharmacotherapy training for fourth-year medical students
por: Gelal, Ayse, et al.
Publicado: (2013)

Computational approaches for rational design of proteins with novel functionalities
por: Tiwari, Manish Kumar, et al.
Publicado: (2012)

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2021)

Towards rational computational peptide design
por: Chang, Liwei, et al.
Publicado: (2022)

Fourth-generation languages /
por: Martin, James, 1933-
Publicado: (1985)

The fourth generation in supergravity
por: Enqvist, Kari, et al.
Publicado: (1985)

Computational Design of Binding Proteins to EGFR Domain II
por: Choi, Yoon Sup, et al.
Publicado: (2014)

Computational Methods Applied to Rational Drug Design
por: Ramírez, David
Publicado: (2016)

Inhibition of synucleinopathic seeding by rationally designed inhibitors
por: Sangwan, Smriti, et al.
Publicado: (2020)

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
por: Du, Xiaojing, et al.
Publicado: (2021)

Search for fourth generation quarks
por: Li, Syue-Wei
Publicado: (2009)

Fourth generation light sources
por: Winick, Herman
Publicado: (1998)

No fourth generation for no-scale models?
por: Enqvist, Kari, et al.
Publicado: (1986)

Limits on Fourth Generation Fermions
por: Ivanov, Andrew
Publicado: (2013)

Fourth Generation Searches at ATLAS
por: Nektarijevic, S
Publicado: (2012)

Fourth-generation light sources
por: Chapman, Henry N.
Publicado: (2023)

Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma
por: Kim, Hye Sook, et al.
Publicado: (2013)

The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors
por: Simčič, Mihael, et al.
Publicado: (2012)

Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors
por: Nanjo, Shigeki, et al.
Publicado: (2013)

Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Ma, Jie-Tao, et al.
Publicado: (2021)

Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
por: Kim, Miso, et al.
Publicado: (2023)

Small-angle X-ray scattering in the era of fourth-generation light sources
por: Narayanan, Theyencheri, et al.
Publicado: (2023)

Rational, computer-aided design of multi-target ligands
por: Achenbach, J, et al.
Publicado: (2011)

Computational Approaches to the Rational Design of Tubulin-Targeting Agents
por: Pérez-Peña, Helena, et al.
Publicado: (2023)

Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial Library
por: Nada, Hossam, et al.
Publicado: (2023)

Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
por: Li, Yufeng, et al.
Publicado: (2023)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014)

Rational Design of Constrained Peptides as Protein Interface Inhibitors
por: Murali, Ramachandran, et al.
Publicado: (2021)

Rational design of small‐molecule responsive protein switches
por: Shui, Sailan, et al.
Publicado: (2023)

Search for Fourth Generation Quarks at CMS
por: Luk, Michael M.H.
Publicado: (2011)

Workshop on fourth generation light sources
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_gcgn0fb3nlk0murvhm1gph8j9a